|
US2019008777A1
|
|
Celecoxib and amlodipine formulation and method of making the same
|
|
IL202272D0
|
|
Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
|
|
EP2268283A2
|
|
Oral modified-release formulations containing thiazepines
|
|
IL193707D0
|
|
Pro-nanodispersion for the delivery of cyclosporin
|
|
EP2167047A2
|
|
Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
|
|
US2006205639A1
|
|
Pro-nanodispersion for the delivery of cyclosporin
|
|
AU2004287373A1
|
|
Stable lansoprazole formulation
|
|
GB0419500D0
|
|
Tetracycline modified release delivery system
|
|
IL159780D0
|
|
Extended release venlafaxine tablet formulation
|
|
NZ528756A
|
|
Oestrus detection system
|
|
EP1473030A1
|
|
Extended release Venlafaxine tablet formulation
|
|
NZ512521A
|
|
Selection system and method for animals for milking and for managing their movement around grazing area
|
|
IL139894D0
|
|
Stable benzimidazole composition and a method for producing it
|
|
IL147232D0
|
|
Stable benzimidazole formulation
|
|
AU1796200A
|
|
Dispersible concentrate for the delivery of cyclosporin
|
|
IL130602D0
|
|
Stable benzimidazole formulation
|
|
IL125891D0
|
|
Omeprazole stabilization method
|
|
IL118932D0
|
|
Controlled release tablets
|
|
IL117677D0
|
|
Controlled release tablets
|
